Media was invaded by news about an attempt of Donald Trump to offer German scientists "a billion dollars" for exclusive rights to a coronavirus vaccine to be used "only for the USA."
The report of this fact was confirmed by the German health ministry. “Germany is not for sale," economy minister Peter Altmaier told broadcaster ARD on Sunday in response. Germany's foreign minister Heiko Mass insisted on Sunday that the government would not allow Trump to push ahead with his plan. On the other part, the US official position denied any vaccine would be exclusive to the US. CureVac, a biopharmaceutical company headquartered in Tübingen, Germany, also denied "rumors of an acquisition" in a March 15 statement.
The firm said it has been in contact with many organizations and global authorities, but "abstains from commenting on speculations and rejects allegations about offers for the acquisition of the company or its technology." On 11 March, CureVac released a statement that its CEO, the US citizen Daniel Menichella, was unexpectedly leaving the firm and would be replaced by the company’s founder, Ingmar Hoerr.The company hopes to have an experimental vaccine ready by June or July so they could seek permission to start testing on humans. The German government was reportedly offering its own financial incentives for the vaccine to stay in the country.